New York S10232 exempts certain cancer treatments from prior authorization requirements based on National Comprehensive Cancer Network Guidelines.

New York S10232 amends the insurance law, public health law, and social services law to exempt certain cancer treatments from prior authorization requirements. Specifically, insurers, managed care plans, and managed care providers are prohibited from requiring prior authorization for cancer treatments categorized as one or two-A by the National Comprehensive Cancer Network's Categories of Evidence and Consensus. However, these entities may still require health care providers to certify that the treatment meets the National Comprehensive Cancer Network Guidelines.

New York S10232 exempts certain cancer treatments from prior authorization requirements based on National Comprehensive Cancer Network Guidelines.

New York S10232 amends the insurance law, public health law, and social services law to exempt certain cancer treatments from prior authorization requirements. Specifically, insurers, managed care plans, and managed care providers are prohibited from requiring prior authorization for cancer treatments categorized as one or two-A by the National Comprehensive Cancer Network's Categories of Evidence and Consensus. However, these entities may still require health care providers to certify that the treatment meets the National Comprehensive Cancer Network Guidelines.